Virgin coconut oil and its potential cardioprotective effects

Postgraduate Medicine

Volumn 126, Issue 7, 2014, Pages 76-83

  Babu, Abraham Samuel ^a   Veluswamy, Sundar Kumar ^a   Arena, Ross ^b   Guazzi, Marco ^c   Lavie, Carl J ^d,e  

^a MANIPAL UNIVERSITY   (India)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Cardiovascular disease; Coconut oil; Diet; Lifestyle intervention

Indexed keywords

C PEPTIDE; CHOLESTEROL OLEATE; COCONUT OIL; GALLIC ACID; OMEGA 3 FATTY ACID; SATURATED FATTY ACID; UNCLASSIFIED DRUG; VIRGIN COCONUT OIL; CARDIOTONIC AGENT; FAT INTAKE; FATTY ACID; VEGETABLE OIL;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DISEASE COURSE; HEART PROTECTION; HUMAN; INSULIN SENSITIVITY; LIPID PEROXIDATION; NONHUMAN; WAIST CIRCUMFERENCE; ANIMAL; CARDIOVASCULAR DISEASES; FAT INTAKE; HEART DISEASES; LIFESTYLE; THERAPEUTIC USE;

ANIMALS; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; DIETARY FATS; FATTY ACIDS; HEART DISEASES; HUMANS; LIFE STYLE; PLANT OILS;

EID: 84925225796     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2014.11.2835     Document Type: Article

References (54)

1. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6–e245.
2. Xu J, Eilat-Adar S, Loria C, et al. Dietary fat intake and risk of coronary heart disease: the Strong Heart Study. Am J Clin Nutr. 2006;84(4):894–902.
3. de Oliveira Otto MC, Mozaffarian D, Kromhout D, et al. Dietary intake of saturated fat by food source and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. 2012;96:397–404.
4. Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA. 2002;288:2569–2578.
5. Lichtenstein AH, Appel LJ, Brands M, et al; American Heart Association Nutrition Committee. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82–96.
6. de Oliveira Otto MC, Wu JH, Baylin A, et al. Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2013;2(6):e000506.
7. Stary HC. Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol. 2000; 20:1177–1178.
8. Degirolamo C, Shelness GS, Rudel LL. LDL cholesteryl oleate as a predictor for atherosclerosis: evidence from human and animal studies on dietary fat. J Lipid Res. 2009;50(Suppl):S434–S439.
9. Methe H, Weis M. Atherogenesis and inflammation—was Virchow right? Nephrol Dial Transplant. 2007;22:1823–1827.
10. Micha R, Khatibzadeh S, Shi P, et al. Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys. BMJ. 2014;348:g2272.
11. Astrup A, Dyerberg J, Elwood P, et al. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am J Clin Nutr. 2011;93:684–688.
12. Fares H, Lavie CJ, DiNicolantonio JJ, O’Keefe JH, Milani RV. Omega-3 fatty acids: a growing ocean of choices. Curr Atheroscler Rep. 2014;16(2):389.
13. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312(19):1205–1209.
14. Hay CR, Durber AP, Saynor R. Effect of fish oil on platelet kinetics in patients with ischaemic heart disease. Lancet. 1982;1(8284): 1269–1270.
15. Micha R, Khatibzadeh S, Shi P, et al. Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys. BMJ. 2014;348:g2272.
16. Calder PC. The role of marine omega-3 (-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol Nutr Food Res. 2012;56(7):1073–1080.
17. Mozaffarian D, Ascherio A, Hu FB, et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation. 2005;111(2):157–164.
18. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58(20):2047–2067.
19. Fats, cooking oils, and fatty acids. http://www.nutristrategy.com/fatsoils. htm. Accessed August 10, 2013.
20. Kinsella JE. Effects of polyunsaturated fatty acids on factors related to cardiovascular disease. Am J Cardiol. 1987;60(12):23G–32G.
21. Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997;337(21): 1491–1499.
22. Chen BK, Seligman B, Farquhar JW, Goldhaber-Fiebert JD. Multicountry analysis of palm oil consumption and cardiovascular disease mortality for countries at different stages of economic development: 1980–1997. Global Health. 2011;7:45.
23. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7:e1000252.
24. Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160:398–406.
25. DiNicolantonio JJ. The cardiometabolic consequences of replacing saturated fats with carbohydrates or -6 polyunsaturated fats: Do the dietary guidelines have it wrong? Open Heart. 2014;1:e000032.
26. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–2757.
27. Harris WS, Dayspring TD, Moran TJ. Omega-3 fatty acids and cardiovascular disease: new developments and applications. Postgrad Med. 2013;125:100–113.
28. Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr. 1982;36(5):950–962.
29. Malhotra A. Saturated fat is not the major issue. BMJ. 2013;347:f6340.
30. Vasudevan DM. Coronary artery disease (atherosclerosis)—an overview and the role of coconut oil in hypercholesterolemia. Indian Coconut J. 2009;72:2–6.
31. Marina AM, CheMan YB, Amin I. Virgin coconut oil: emerging functional food oil. Trends Food Sci Technol. 2009;20:481–487.
32. Carandang EV. Health benefits of virgin coconut oil. Indian Coconut J. 2008;71:8–12.
33. Gopala Krishna AG, Raj G, Bhatnagar AS, Prasanth Kumar PK, Chandrashekar P. Coconut oil: chemistry, production and its applications— a review. Indian Coconut J. 2010;73:15–27.
34. Mansor TST, Che Man YB, Shuhaimi M, Abdul Afiq MJ, Ku Nurul FKM. Physicochemical properties of virgin coconut oil extracted from different processing methods. Int Food Res J. 2012;19:837–845.
35. Mandal MD, Mandal S. Coconut (Cocos nucifera L.: Arecaceae): in health promotion and disease prevention. Asian Pacific J Trop Med. 2011;4:241–247.
36. Marina AM, Che Man YB, Nazimah SAH, Amin I. Chemical properties of virgin coconut oil. J Am Oil Chem Soc. 2009;86:301–307.
37. D’Aquino M, Benedetti PC, Di Felice M, et al. Effect of fish oil and coconut oil on antioxidant defence system and lipid peroxidation in rat liver. Free Radic Res Commun. 1991;12–13(Pt 1):147–152.
38. Marina AM, Che Man YB, Nazimah SAH, Amin I. Chemical properties of virgin coconut oil. J Am Oil Chemists Soc. 2009;86:301–307.
39. Vysakh A, Ratheesh M, Rajmohanan TP, et al. Polyphenolics isolated from virgin coconut oil inhibits adjuvant induced arthritis in rats through antioxidant and anti-inflammatory action. Int Immunopharmacol. 2014;20(1):124–130.
40. Nevin KG, Rajamohan T. Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation. Clin Biochem. 2004; 37(9):830–835.
41. Hamsi MA, Othman F, Das S, et al. Effect of consumption of fresh and heated virgin coconut oil on the blood pressure and inflammatory biomarkers: an experimental study in Sprague-Dawley rats [published online ahead of print March 27, 2014]. Alexandria J Med. No doi available.
42. Nevin KG, Rajamohan T. Influence of virgin coconut oil on blood coagulation factors, lipid levels and LDL oxidation in cholesterol fed Sprague-Dawley rats. e-SPEN. 2008;3:e1–e8.
43. Nevin KG, Rajamohan T. Virgin coconut oil supplemented diet increases the antioxidant status in rats. Food Chem. 2006;99:260–266.
44. Nevin KG, Rajamohan T. Wet and dry extraction of coconut oil: impact on lipid metabolic and antioxidant status in cholesterol coadministered rats. Can J Physiol Pharmacol. 2009;87(8):610–616.
45. Nurul-Iman BS, Kamisah Y, Jaarin K, Qodriyah HM. Virgin coconut oil prevents blood pressure elevation and improves endothelial functions in rats fed with repeatedly heated palm oil. Evid Based Complement Alternat Med. 2013;2013:629329.
46. Prior IA, Davidson F, Salmond CE, Czochanska Z. Cholesterol, coconuts, and diet on Polynesian atolls: a natural experiment: the Pukapuka and Tokelau island studies. Am J Clin Nutr. 1981;34(8):1552–1561.
47. Lipoeto NI, Agus Z, Oenzil F, Wahlqvist M, Wattanapenpaiboon N. Dietary intake and the risk of coronary heart disease among the coconutconsuming Minangkabau in West Sumatra, Indonesia. Asia Pacific J Clin Nutr. 2004;13(4):377–384.
48. Han JR, Deng B, Sun J, et al. Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism. 2007;56(7):985–991.
49. Assunção ML, Ferreira HS, dos Santos AF, Cabral CR Jr, Florêncio TM. Effects of dietary coconut oil on the biochemical and anthropometric profiles of women presenting abdominal obesity. Lipids. 2009;44(7):593–601.
50. Liau KM, Lee YY, Chen CK, Rasool AH. An open-label pilot study to assess the efficacy and safety of virgin coconut oil in reducing visceral adiposity. ISRN Pharmacol. 2011;2011:949686.
51. Sabitha P, Vasudevan DM. Lipid profile and antioxidant enzymes in coconut oil consumers. Indian Coconut J. 2010;73:3–6.
52. Degirolamo C, Rudel LL. Dietary monounsaturated fatty acids appear not to provide cardioprotection. Curr Atheroscler Rep. 2010;12(6):391–396.
53. Ros E, Martínez-González MA, Estruch R, et al. Mediterranean diet and cardiovascular health: teachings of the PREDIMED study. Adv Nutr. 2014;5(3):330S–336S.
54. Liau KM, Lee YY, Chen CK, Rasool AH. An open-label pilot study to assess the efficacy and safety of virgin coconut oil in reducing visceral adiposity. ISRN Pharmacol. 2011;2011:949686.